Cite
HARVARD Citation
Elbadawi, M. et al. (2022). 2-Arylquinolines as novel anticancer agents with dual EGFR/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights. Journal of enzyme inhibition and medicinal chemistry. pp. 355-378. [Online].